Skip to main content
 

Alerts and Recalls

Top
  • Hurricane Harvey—Clinical Guidance for Carbon Monoxide (CO) Poisoning

    Tuesday, September 5, 2017
    When power outages occur during emergencies such as hurricanes or winter storms, the use of alternative sources of fuel or electricity for heating, cooling, or cooking can cause CO to build up in a home, garage, or camper and poison the people and animals inside. Although CO poisoning can be fatal...

    Read More
  • Hospira Issues Voluntary Worldwide Recall For Lots of Hydromorphone HCl Injection

    Friday, September 1, 2017
    Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Hydromorphone HCI Injection, USP, CII (2 mg/mL) 1mg/mL Vial and four lots of Levophed® (Norepinephrine Bitartrate Injection, USP), 4 mg/4 mL (1 mg/mL) Vial due to a potential lack of sterility assurance resulting from use of a...

    Read More
  • Alcohol Pads or Benzalkonium Chloride Antiseptic Towelettes by Foshan Flying Medical Products: FDA Alert - Lack of Sterility Assurance and Other Quality Issues

    Friday, September 1, 2017
    The U.S. Food and Drug Administration is alerting health care professionals and patients not to use alcohol pads or benzalkonium chloride antiseptic towelettes made by Foshan Flying Medical Products Co. Ltd., located in China, due to the lack of sterility assurance and other quality issues.

    Read More
  • Keytruda (pembrolizumab) in Patients with Multiple Myeloma: FDA Statement - Two Clinical Trials on Hold

    Thursday, August 31, 2017
    Based on data from two recently halted clinical trials, the U.S. Food and Drug Administration today is issuing this statement to inform the public, health care professionals, and oncology clinical investigators about the risks associated with the use of Keytruda (pembrolizumab) in combination with...

    Read More
  • Vancomycin Hydrochloride for Injection, USP, 750 mg/vial by Hospira: Recall - Presence of Particulate Matter

    Thursday, August 31, 2017
    Hospira is voluntarily recalling one lot of Vancomycin Hydrochloride for Injection, USP, 750 mg/vial (NDC 0409-6531-02) lot 632153A, to the hospital/retailer level. The recall was due to a confirmed customer report for the presence of particulate matter, confirmed as glass, within a single vial.

    Read More
  • Implantable Cardiac Pacemakers by Abbott (formerly St. Jude Medical): Safety Communication - Firmware Update to Address Cybersecurity Vulnerabilities

    Tuesday, August 29, 2017
    On August 23, 2017, the FDA approved a firmware update that is now available and is intended as a recall, specifically a corrective action, to reduce the risk of patient harm due to potential exploitation of cybersecurity vulnerabilities for certain Abbott (formerly St. Jude Medical) pacemakers.

    Read More
  • Texas Board of Nursing (BON) to Implement Disaster Licensing Procedure

    Tuesday, August 29, 2017
    The Texas BON is implementing a disaster licensing procedure to respond to this declared disaster.

    Read More
  • ESRD Network of Texas Disaster Updates

    Sunday, August 27, 2017
    ESRD Network of Texas maintains a comprehensive list of resources and materials on their website. The Network also actively participates in the Texas ESRD Emergency Coalition (TEEC).

    Read More
  • Harvey: A Life Threatening Hurricane

    Friday, August 25, 2017
    Hurricane Harvey is a life-threatening and rapidly intensifying storm that is expected to make landfall on the Texas Gulf Coast with devastating rainfall flooding, dangerous storm surge flooding, and destructive winds.

    Read More
  • Bella Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of All Sterile Drug Products Due to Lack of Sterility Assurance

    Monday, August 21, 2017
    Bella Pharmaceuticals is voluntarily recalling all lots of unexpired sterile drug products due to lack of sterility assurance. The recalled products were distributed to health care facilities nationwide.

    Read More